Cavernous sinus thrombosis risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}}{{MMJ}} | {{CMG}}; {{AE}}{{MMJ}} | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of cavernous sinus thrombosis include: [[Neoplasms]], [[Facial|facial infections]], [[sinusitis]], [[otitis media]], [[Dental|dental infections]], [[sepsis]], [[factor V Leiden mutation]][[Prothrombin G20210A mutation|, Prothrombin G20210A mutation]], [[antithrombin III deficiency]], [[Protein S deficiency|protein C or S deficiency]], increased [[factor VIII]], [[antiphospholipid antibody syndrome]], [[Hyperhomocysteinemia|hyperhomocysteinemia,]] [[heparin-induced thrombocytopenia]], [[pregnancy]], [[obesity]], [[dehydration]], [[autoimmune disease]], [[Diabetes|uncontrolled diabetes]], [[Steroid|steroid use]], [[chemotherapy]], [[oral contraceptives]] or [[hormone replacement therapy]] and [[Inflammatory bowel disease|inflammatory bowel diseases]]. Less common risk factors in the development of cavernous sinus thrombosis include: [[Puerperium]], [[fibrous thyroiditis]], [[Arteriovenous malformation|arterio-venous malformations]] and[[immunosuppression]]. | |||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors in the development of cavernous sinus thrombosis include: [[Neoplasms]], [[Facial|facial infections]], [[sinusitis]], [[otitis media]], [[Dental|dental infections]], [[sepsis]], [[factor V Leiden mutation]][[Prothrombin G20210A mutation|, Prothrombin G20210A mutation]], [[antithrombin III deficiency]], [[Protein S deficiency|protein C or S deficiency]], increased [[factor VIII]], [[antiphospholipid antibody syndrome]], [[Hyperhomocysteinemia|hyperhomocysteinemia,]] [[heparin-induced thrombocytopenia]], [[pregnancy]], [[obesity]], [[dehydration]], [[autoimmune disease]], [[Diabetes|uncontrolled diabetes]], [[Steroid|steroid use]], [[chemotherapy]], [[oral contraceptives]] or [[hormone replacement therapy]] and [[Inflammatory bowel disease|inflammatory bowel diseases]]. | |||
===Common Risk Factors=== | ===Common Risk Factors=== | ||
*Common risk factors in the development of cavernous sinus thrombosis may be occupational, environmental, genetic, and viral.<ref name="pmid19383052">{{cite journal| author=Saadatnia M, Fatehi F, Basiri K, Mousavi SA, Mehr GK| title=Cerebral venous sinus thrombosis risk factors. | journal=Int J Stroke | year= 2009 | volume= 4 | issue= 2 | pages= 111-23 | pmid=19383052 | doi=10.1111/j.1747-4949.2009.00260.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19383052 }} </ref> | *Common risk factors in the development of cavernous sinus thrombosis may be occupational, environmental, genetic, and viral.<ref name="pmid19383052">{{cite journal| author=Saadatnia M, Fatehi F, Basiri K, Mousavi SA, Mehr GK| title=Cerebral venous sinus thrombosis risk factors. | journal=Int J Stroke | year= 2009 | volume= 4 | issue= 2 | pages= 111-23 | pmid=19383052 | doi=10.1111/j.1747-4949.2009.00260.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19383052 }} </ref> | ||
*Common risk factors in the development of cavernous sinus thrombosis include:<ref name="pmid19383052">{{cite journal| author=Saadatnia M, Fatehi F, Basiri K, Mousavi SA, Mehr GK| title=Cerebral venous sinus thrombosis risk factors. | journal=Int J Stroke | year= 2009 | volume= 4 | issue= 2 | pages= 111-23 | pmid=19383052 | doi=10.1111/j.1747-4949.2009.00260.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19383052 }} </ref> | *Common risk factors in the development of cavernous sinus thrombosis include:<ref name="pmid19383052">{{cite journal| author=Saadatnia M, Fatehi F, Basiri K, Mousavi SA, Mehr GK| title=Cerebral venous sinus thrombosis risk factors. | journal=Int J Stroke | year= 2009 | volume= 4 | issue= 2 | pages= 111-23 | pmid=19383052 | doi=10.1111/j.1747-4949.2009.00260.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19383052 }} </ref> | ||
**Neoplasms | **[[Neoplasms]] | ||
**Infections: | **Infections: | ||
***Facial | ***[[Facial]] infections | ||
***Sinusitis | ***[[Sinusitis]] | ||
***Otitis media | ***[[Otitis media]] | ||
***Dental infections | ***[[Dental|Dental infections]] | ||
***Sepsis | ***[[Sepsis]] | ||
**Thrombophilic genetic disorders such as: | **[[Thrombophilic disorders|Thrombophilic genetic disorders]] such as: | ||
***Factor V Leiden mutation | ***[[Factor V Leiden mutation]] | ||
***Prothrombin G20210A mutation | ***[[Prothrombin G20210A mutation]] | ||
***Antithrombin III deficiency | ***[[Antithrombin III deficiency]] | ||
***Protein C or S deficiency | ***[[Protein S deficiency|Protein C or S deficiency]] | ||
***Increased factor VIII | ***Increased [[factor VIII]] | ||
**Acquired thrombophilic disorders such as: | **Acquired [[thrombophilic disorders]] such as: | ||
***Antiphospholipid antibody syndrome | ***[[Antiphospholipid antibody syndrome]] | ||
***Hyperhomocysteinemia | ***[[Hyperhomocysteinemia]] | ||
***Heparin-induced thrombocytopenia | ***[[Heparin-induced thrombocytopenia]] | ||
**Pregnancy | **[[Pregnancy]] | ||
**Obesity | **[[Obesity]] | ||
**Dehydration | **[[Dehydration]] | ||
**Autoimmune disease | **[[Autoimmune disease]] | ||
**Uncontrolled diabetes | **[[Diabetes|Uncontrolled diabetes]] | ||
**Steroid use | **[[Steroid|Steroid use]] | ||
**Chemotherapy | **[[Chemotherapy]] | ||
**Oral contraceptives or hormone replacement therapy | **[[Oral contraceptives]] or [[hormone replacement therapy]] | ||
**Inflammatory bowel diseases | **[[Inflammatory bowel disease|Inflammatory bowel diseases]] | ||
===Less Common Risk Factors=== | ===Less Common Risk Factors=== | ||
*Less common risk factors in the development of | *Less common risk factors in the development of cavernous sinus thrombosis include: | ||
**Puerperium | **[[Puerperium]] | ||
**Fibrous thyroiditis | **[[Fibrous thyroiditis]] | ||
**Arterio-venous malformations | **[[Arteriovenous malformation|Arterio-venous malformations]] | ||
**Immunosuppression | **[[Immunosuppression]] | ||
==References== | ==References== | ||
Revision as of 15:46, 28 June 2018
|
Cavernous sinus thrombosis Microchapters |
|
Differentiating Cavernous sinus thrombosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cavernous sinus thrombosis risk factors On the Web |
|
American Roentgen Ray Society Images of Cavernous sinus thrombosis risk factors |
|
Risk calculators and risk factors for Cavernous sinus thrombosis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
Common risk factors in the development of cavernous sinus thrombosis include: Neoplasms, facial infections, sinusitis, otitis media, dental infections, sepsis, factor V Leiden mutation, Prothrombin G20210A mutation, antithrombin III deficiency, protein C or S deficiency, increased factor VIII, antiphospholipid antibody syndrome, hyperhomocysteinemia, heparin-induced thrombocytopenia, pregnancy, obesity, dehydration, autoimmune disease, uncontrolled diabetes, steroid use, chemotherapy, oral contraceptives or hormone replacement therapy and inflammatory bowel diseases. Less common risk factors in the development of cavernous sinus thrombosis include: Puerperium, fibrous thyroiditis, arterio-venous malformations andimmunosuppression.
Risk Factors
Common risk factors in the development of cavernous sinus thrombosis include: Neoplasms, facial infections, sinusitis, otitis media, dental infections, sepsis, factor V Leiden mutation, Prothrombin G20210A mutation, antithrombin III deficiency, protein C or S deficiency, increased factor VIII, antiphospholipid antibody syndrome, hyperhomocysteinemia, heparin-induced thrombocytopenia, pregnancy, obesity, dehydration, autoimmune disease, uncontrolled diabetes, steroid use, chemotherapy, oral contraceptives or hormone replacement therapy and inflammatory bowel diseases.
Common Risk Factors
- Common risk factors in the development of cavernous sinus thrombosis may be occupational, environmental, genetic, and viral.[1]
- Common risk factors in the development of cavernous sinus thrombosis include:[1]
- Neoplasms
- Infections:
- Facial infections
- Sinusitis
- Otitis media
- Dental infections
- Sepsis
- Thrombophilic genetic disorders such as:
- Acquired thrombophilic disorders such as:
- Pregnancy
- Obesity
- Dehydration
- Autoimmune disease
- Uncontrolled diabetes
- Steroid use
- Chemotherapy
- Oral contraceptives or hormone replacement therapy
- Inflammatory bowel diseases
Less Common Risk Factors
- Less common risk factors in the development of cavernous sinus thrombosis include:
References
- ↑ 1.0 1.1 Saadatnia M, Fatehi F, Basiri K, Mousavi SA, Mehr GK (2009). "Cerebral venous sinus thrombosis risk factors". Int J Stroke. 4 (2): 111–23. doi:10.1111/j.1747-4949.2009.00260.x. PMID 19383052.